Introduction: This pilot series sought to assess the use of external ultrasound stimulation (Exogen TM ) in the treatment of femoral or tibial non-union. Materials and methods: A continuous retrospective study was conducted from 2004 to 2009. It included patients with a non-united fracture or osteotomy at 6 months or more post-surgery, with less than 10 mm inter-fragment gap. Daily 20-min ultrasound sessions were continued until bone healing was achieved or for a maximum 6-month duration. Radio-clinical control was performed at months 3 and 6; treatment compliance and transmitter positioning were checked at each follow-up visit. Results: Sixty non-unions were included in the series. One patient was excluded for early material breakage. Mean fracture-to-surgery interval was 271 days. The 6-month consolidation rate was 88%. There was no loss to follow-up. Mean ultrasound treatment duration was 151 days (range, 90-240 days). Bone healing correlated significantly with stability of the internal fixation assembly (P = 0.01). The seven cases of failure included four fixations,considered unstable at inclusion, one femoral non-union associated with BMI 45 and one inadequate subchondral roughening (at the time of arthrodesis). There was a significant difference in delay to non-union treatment start between the groups with (251 days) and without (420 days) bone healing. Discussion: The present results are in line with the literature. The main prognostic factors were fracture fixation stability, short time to treatment, and inter-fragment gap less than 10 mm. Bone healing rates in the literature are around 80% for non-union treated at around 6 months, versus 60% for more than 12 months' delay. Factors such as gender, bone site, smoking, numbers of previous operations or type of osteosynthesis do not impact consolidation. External treatment offers an alternative to traditional surgery (graft, or bone-marrow concentrate or bone morphogenetic protein injection), provided that the fracture fixation is stable. Bone healing rates are better, and the procedure is non-invasive. External treatment results using ultrasound
Introduction
External stimulation is currently being developed for the treatment of non-union. In France, there are no database (whether under the Health Authority or by the National health insurance agency) enabling how widespread their use is to be judged. From the literature [1] , however, and manufacturers' sales figures, it can be estimated that the number of patients rose from 22 in 2004 to more than 1000 in 2010. In France, two devices are available: PhysioStim TM (using electromagnetic fields) and Exogen TM (using ultrasound). They may be used on condition that the interval following trauma is at least 6 months and the inter-fragment gap at the nonunion site is less than 10 mm. They represent an alternative to the reference attitude of corticocancellous graft, Judet decortication or local osteoinductive injection (bone morphogenetic protein or bone-marrow concentrate).
The present pilot study sought to assess results using Exogen TM in non-union in adults and the limitations of the technique. . The signal induces a nanomovement in the intercellular matrix at the non-union site, which is recognized by the bone-cell membrane integrins. At cell level, the signal [2] [3] [4] [5] induces synthesis of proteins involved in angiogenesis (vascular endothelial growth factor [VEGF]), osteogenesis (osteocalcin), bone mineralization (alkaline phosphatase), matrix (type-1 collagen and fibronectin), bone consolidation (prostaglandin E2) and matrix remodeling (matrix metalloproteinase [MMP] ).
Material and method
The inclusion criteria met the 2002 Afssaps (French medical product safety authority) recommendations: fracture with first-line surgery, non-consolidated at 6 months, with inter-fragment gap less than 10 mm; non-unions secondary to osteotomy or arthrodesis were also included. Exclusion criteria were: pregnancy, congenital non-union, and spine or skull fracture. During the period 2004 to 2009, all cases of non-union meeting these inclusion criteria were managed using the Exogen TM system. Electromagnetic field treatment was reserved for nonunion in fracture with first-line conservative management (mainly clavicle and scaphoid fracture). Non-union with inter-fragment gap more than 10 mm was managed surgically.
Non-union was confirmed on antero posterior (AP) and strict lateral X-ray at inclusion by the absence of any cortical or cancellous bone bridge. In case of tight non-union or bulky osteosynthesis material hindering cortical analysis, CT was systematically performed to check absence of any continuous bridge at the site.
Osteosynthesis stability was assessed at inclusion, based on clinical and radiological data. Stability was defined clinically as absence of fracture mobility (frontal, sagittal or rotational) and radiologically as absence of mobility chamber in the osteosynthesis material (Fig. 1) .
The interval between trauma and initiation of external stimulation was recorded, as were the number of previous surgical operations for delayed consolidation. Patient data on smoking, height and weight were collected and body-mass index was calculated.
To position the transmitter, an AP X-ray view of the nonconsolidated fracture was taken and a radio-opaque mark was made on the skin over the fracture site, which was usually on the anterior side of the limb. The affected bone segment was not immobilized, with motion limited only by criteria of pain. Treatment was 20 min daily until consolidation or a maximum of 6 months. Patients were followed up at 6 weeks, and 3 and 6 months after initiation of stimulation. AP and lateral X-rays views were taken at each consultation, plus CT at 3 and 6 months. At each consultation, the patient was asked to indicate the transmitter site and compliance was checked by a monitor on the device, which showed the number of treatment cycles the patient had performed at home.
Consolidation was checked clinically (absence of pain on axial and rotational stress) and radiologically on plain AP and lateral views at 6 months (continuity of at least three corticals). Radiological consolidation was confirmed by an independent investigator.
Statistics
Statistical analysis used Fisher's exact test and the MannWhitney test for medians. It was performed by the institution's biostatistics department.
Results
Between 2004 and 2009, 60 cases of diaphyseal or metaphyseal fracture non-union were included: 38 males, 22 females; mean age, 43 years (range, 17-85 yrs). Table 1 presents the bone segments and types of osteosynthesis.
One patient was excluded at week 4 of stimulation, due to a fractured nail: this was a 25-year-old woman with bilateral femoral fracture treated by nailing. The right femur had consolidated in 4 months; the left showed atrophic non-union, subjected to ultrasound after 500 days (i.e., 16 months). Nailing was repeated, and consolidation was achieved after 6 months. Table 2 shows data for the remaining 59 patients: gender, age, bone segment concerned, initial treatment, number and type of surgical procedures for non-union prior to the external stimulation, non-union site inter-fragment gap, osteosynthesis stability, interval before stimulation, non-union aspect, smoking status (cigarettes/day) and consolidation at 6-month' follow-up.
The mean interval between fracture or osteotomy and initiation of ultrasound stimulation was 271 days (range, 166 to 1394 days). Mean inter-fragment gap at the non-union site was 4 mm (2-0 mm). Non-union was atrophic in 58 cases and hypertrophic in one (Fig. 2) . In five cases, osteosynthesis was considered unstable at inclusion:
• one diaphyseal humeral fracture initially treated by nailing and simple proximal locking with more than 45
• rotational motion on clinical examination; • one ulnar diaphysis non-union treated by plate with mobility chamber at the three proximal screws of the plate; • one ulnar diaphysis non-union associated with olecranon fracture, with nail retreat and defective rig tightening; • one tibial non-union treated by screwing;
• one fibular non-union with broken plate.
Mean treatment duration was 151 days (range, 90-240 days). There were no locoregional complications related to device positioning. The built-in monitor confirmed good compliance, with a non-compliance rate of less than 5% per patient; this rate did not correlate with treatment failure.
The 6-month consolidation rate following external stimulation was 88% (seven failures out of 59).
Statistically, final consolidation was not significantly related to age (P = 0.68), gender, bone segment and nonunion site, BMI, primary osteosynthesis type (P = 0.30), smoking status (P = 0.38), number of previous procedures (P = 0.15) or non-union site inter-fragment gap (P = 0.62).
The mean interval to treatment tended to differ according to consolidation following external stimulation: 251 days in the group showing consolidation at follow-up, versus 420 days in the group comprising the seven failures; the difference, however, was not significant (P = 0.06). There was a significant relation (P = 0.01) between stable osteosynthesis and final consolidation.
The group of seven failures comprised one femoral shaft non-union with nail (stable osteosynthesis, but pathological BMI at 47); four non-unions judged unstable at inclusion; one subtalar non-union with primary subchondral stripping defect; and one lateral malleolar non-union (stable osteosynthesis but using a single retrograde nail).
Discussion
Immediate post-traumatic adjuvant use of ultrasound has been validated in several studies. Consolidation time in recent fracture was reduced by about 30 to 40% [1, [6] [7] [8] [9] .
Application in non-union was first described by Xavier and Duarte [10, 11] in 1983, with a 70% consolidation rate in a series of 28 cases.
In 1997, Mayr et al. [12] , in a retrospective series of 877 cases of delayed consolidation divided into two groups (636 simple delays, treated by Exogen TM as of day 90 to 269 posttrauma, and 241 non-unions with treatment initiated as of day 270 post-trauma), reported 90% consolidation in simple delay and 85% in non-union. Factors for poor prognosis for bone consolidation were renal insufficiency, arteritis and smoking; primary osteosynthesis stability was not examined.
Rutten et al. [13] , in a series of 71 lower-limb fractures with delayed consolidation, reported a 73% consolidation rate, but did not analyze causes of failure.
Nolte et al. [14] , in 2001, reported a clinical series of 29 cases of non-union treated by ultrasound. Bone segment distribution was similar to that in the present series. The mean interval between initial fracture and initiation of external stimulation was 61 weeks (i.e., 15 months), with a consolidation rate of 86%. Primary osteosynthesis stability was not examined.
Gebauer et al. [15] , in 2005, in a series of 67 cases of consolidation delay exceeding 8 months, reported an 85% consolidation rate. Exclusion criteria were contact defect, unstable osteosynthesis or evolutive sepsis. As in the present series, external therapy was shown to be contra-indicated in case of unstable osteosynthesis.
Schofer et al. [16] , in 2010, published a level-I study of 101 tibial shaft fractures with delayed consolidation at 4 months post-trauma, comparing the Exogen TM device versus an identical but inactive device case. Exogen TM significantly improved bone mineralization (P = 0.002) and reduced fracture gap (P = 0.014).
The present 88% consolidation rate is comparable to those of recent series.
Examining patient data, neither age nor gender seemed to impact the success of external stimulation. Obesity is a parameter that was not analyzed in previous reports. Elevated BMI (> 40) appeared to be a factor of failure, taking account of the bone site and adipose tissue thickness. The transmitter is harder for the patient to position correctly on the skin over the fracture site, due to lack of subcutaneous bone relief, and there is a loss of signal intensity, due to diffusion, at the non-union. External treatment is probably not indicated in proximal and diaphyseal femoral non-union in case of BMI more than 40.
Figure 2
Tibial non-union after derotation osteotomy for mal-union following nailing. Postoperative radiography: radiograph at 7 months after derotation, situation of non-union; radiograph at 6 months of exogen stimulation; radiograph at 12 weeks of stimulation, tibial union.
In the present series, as reported by Kyro et al. [17] , smoking did not correlate with failure of Exogen TM stimulation. The overall smoking rate was 28%, with 11% in the consolidation group and 14% in the consolidation failure group. The influence of smoking as a factor in non-union consolidation probably becomes negligible next to local post-traumatic factors: macro-mobility, periosteal lesion and muscle mass lesion.
The present series was too small to analyze the influence of non-union site on consolidation. This parameter was assessed by Franckel et al. [18] in a registry of 404 cases of delayed consolidation: consolidation rates were 70% for the humerus, 86% for the femur, 81% for the metatarsals, 96% for the scaphoid and 83% for the tibia. Osteosynthesis stability according to surgical site and intervals to treatment were not analyzed.
The interval before non-union treatment showed a trend to be longer in the external stimulation failure group, although the difference was not significant (P = 0.06). Consolidation cannot be boosted unless callous ossification is still ongoing. Stromkvist et al. [19] showed that longstanding non-union no longer exhibited ossification on scintigraphy. External stimulation has to be initiated at an early stage, before the callous tissue loses its ossification potential (continuing osteoblast activity at the site, with peripheral hyperemia) and before onset of synovial non-union.
Rubin et al. [20] , in a registry analysis, confirmed the impact of time to initiation of external stimulation therapy: success rates were comparable in fracture treated between days 91 and 150 (1790 fractures) and between days 151 and 255 (1370 fractures), at 91% and 89% respectively, but fell to 83% in the 1540 fractures, treated later than day 255. Six months would seem to be the interval after which consolidation rates with external stimulation seem to diminish -and unfortunately corresponds in France to the minimum interval required for national health insurance coverage of the treatment. This 6-month interval requirement and the restriction of external stimulation therapy to non-union at surgical (fracture or osteotomy) sites are specific to France: in the USA, for example, Exogen TM has Food and Drugs Administration (FDA) approval for recent fracture and for delayed consolidation of whatever origin (surgically or conservatively managed fracture or osteotomy).
A long interval before treatment (exceeding 12 months from trauma) is not a contra-indication for external stimulation: the consolidation rate with ultrasound in such cases approaches 60% [9] . This lower success rate is to be seen against the technical difficulty and complications associated with traditional surgery by graft or decortication.
This relation between ''active'' callous tissue and response to ultrasound was also found in hypertrophic nonunion. Given stable osteosynthesis, the success rate for external stimulation in this indication approached 100%; in agreement with Mayr et al. [12, 21, 22] , failure in the present series concerned atrophic non-union.
Osteosynthesis stability is essential to consolidation. In agreement with Gebauer et al. [15] , we consider nonunion showing macro-mobility due to material (nail or plate) breakage or to deficient primary osteosynthesis rigidity to be a formal contra-indication to external stimulation therapy. Such cases should be managed by conventional surgical revision of the osteosynthesis with osteoinduction at the non-union site (autograft, Judet decortication, autologous bone marrow or bone morphogenetic protein injection).
In non-union with stable osteosynthesis, the Exogen TM system provides an alternative to osteoinduction-based surgical procedures:
• cancellous or corticocancellous graft; Judet decortication (80% mean consolidation, according to the literature); • Bone Morphogenic Protein (BMP) injection (Friedlander et al. [23] reported 75% consolidation); • or autologous bone marrow injection (Hernigou et al. [24] reported 71% consolidation).
These procedures have the drawback of potential comorbidity (graft rejection, anesthesia), with consolidation rates no better than with external therapy. They may be indicated in traumatology for bone defects of 10 to 40 mm or for fracture gaps of less than 10 mm if the osteosynthesis needs revising (material breakage, stability defect, etc.). Fig. 3 presents a flowchart for the management of consolidation in case of more than or equal to 6 months' postoperative delay.
The direct competitor of the Exogen TM system is pulsed electromagnetic field therapy. In France, only the PhysioStim TM system has national health coverage for a similar indication (6-month post-fracture delay in consolidation, inter-fragment gap inferior to 10 mm). The one difference is the possibility of treating fractures initially managed conservatively. PhysioStim TM is applied for 3 hours per day. The armband emitting the electromagnetic field is wide (increased target bone area) and allows application at the root of the limb. Garland et al. [25] reported 75% consolidation (181 patients for 193 fractures), and found no correlation with age, gender, age of non-union or fracture gap size; osteosynthesis stability was not analyzed. The success rate was unaffected by previous osteoinduction surgery. The study, however, involved several biases, with 23% of patients not adhering to a minimal 12 weeks' treatment, and multicenter data collection (74 institutions for 181 patients: i.e., on average, less than three patients per center).
Financially, the unit cost for external therapy on the French system is D 1772 -much less than for the ''decortication with or without complementary osteosynthesis'' procedure (coded GHM 08c50), which is invoiced at D 4480.22 (as of March 1st, 2011) for hospital costs for a patient free of comorbidity, without taking account of postoperative home-care costs or the time off work for hospital admission. The financial advantage of external therapy was confirmed by Heckman and Kahn [26] , in an American series of tibial fracture, who reported overall cost-saving of $ 13,000 to $ 15,000.
Conclusion
The present series confirmed the literature findings, with a consolidation rate of 80%. Two essential criteria are to be considered in indicating external therapy: non-union site inter-fragment gap less than 10 mm, and stable osteosynthesis. The Exogen TM stimulation system can then be indicated as first-line treatment, as its success rate is better than with any osteoinduction surgery. The technique is noninvasive, and should be implemented early, as of 6-month post-trauma. Cost saving for society, using external therapy rather than a classical surgical procedure such as grafting, may be estimated at between D 2000 and D 8000.
